Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

23 Oct 2018

• By Mandy Jackson

Finance Watch

Related Content

Pipeline Watch: Phase III Top-Line Data With Givosiran, Soliris and Vascepa

01 Oct 2018

REPAIR Is Trying To Fix The Antibiotic Gap Left By Industry

12 Sep 2018

Novel-Mechanism Antibacterials And Microbiome-Friendly Agents Now Key For Summit Therapeutics

11 Sep 2018

Finance Watch: Rakuten Aspyrian Raises $150m VC Round For Laser-Activated Cancer Drugs

24 Aug 2018

Tetraphase's Broad Spectrum Antibiotic Xerava Priced To Move

28 Aug 2018

Paratek's Antibiotic Nuzyra Survived 20 Years – Now For The US Launch

03 Oct 2018

IPO Update: Returns Sag As Seven More Biopharmas Go Public In September

02 Oct 2018

Finance Watch: VC Tally Hits $14.5bn For 2018, Beating 2017 With A Quarter Left To Go

16 Oct 2018

Medicines Company gains anti-infectives in $140m Rempex buy

05 Dec 2013

AMR Roundtable: The Push And Pull Of Antimicrobial Development Incentives (Part 1)

17 Jul 2017

Nabriva Gains New CEO And Near-Market Antibiotic, Claims Leadership Role

25 Jul 2018

Venture Funding Deals: Celularity Launches With $250m; Generation Bio Grabs $100m Series B

06 Mar 2018

Alarm As Novartis Exits Antibiotics Space

12 Jul 2018

BARDA backs Medicines/Rempex antibiotic with $90m award

06 Feb 2014

VC Roundup: Early-Stage Funding Slips Again In Third Quarter, Plus 15 New Financings

08 Oct 2016

CARB-X Partnership Puts Antibiotics' Future In Biotech Startups' Hands

30 Jul 2016

VC Roundup: Caribou Completes $30m Non-IPO CRISPR Financing; $205m In Cash For Five Others

16 May 2016

Circle Of Life: Raptor Buys Quinsair After Its Return To Original Developer

22 Aug 2015

Raptor Buy Bolsters Horizon's Orphan Business As Primary Care Foots The Bill

13 Sep 2016

New Report Calls For Pushing And Pulling In Global Fight Against Superbugs

24 Jan 2018

Finance Watch: Bicycle Spins Toward Clinic With $52m Round; Stock Spikes Spur Offerings

02 Jun 2017

Melinta Expands Portfolio, TMC Narrows Focus To LDL Reduction With Anti-Infective Deal

29 Nov 2017

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma

21 Nov 2017

Deals Shaping the Medical Industry, December 2016

08 Dec 2016

US Approval Of Vabomere Could Help Alleviate TMC's Financial Troubles

31 Aug 2017

Related Companies

The Medicines Company

Horizon Therapeutics plc

Raptor Pharmaceutical Corp.

Horizon Therapeutics plc

Melinta Therapeutics, Inc.

Paratek Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

AstraZeneca PLC

Entasis Therapeutics Holdings Inc.

Summit Therapeutics plc

Nabriva Therapeutics plc.

Otsuka Holdings Co., Ltd.

Arcus Biosciences, Inc.

Harpoon Therapeutics

STORM Therapeutics Ltd

ORIC Pharmaceuticals, Inc.

Quentis Therapeutics Inc.

Turning Point Therapeutics Inc.

GSK plc

Castle Creek Biosciences, Inc.

Paragon Biosciences LLC

University of North Carolina at Chapel Hill

Additional Topics

Financing StartUps and SMEs Business Strategies Deals Commercial Infectious Diseases BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.